Find Clinical Trials
A 24 months, prospective, randomized, double-blind study to assess the effect of daily oral administration of 2 g of strontium ranelate versus placebo on bone mineral density in postmenopausal osteoporotic women previously treated with bisphosphonates
Servier Protocol Code:
CL3-12911-038
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2011-000708-17
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Osteoporosis
- S012911
- STRONTIUM RANELATE
Other study id numbers
Other identification numbers the study may be known by.
- CL3-12911-038